Probably the only thing we have in common is that we own shares...

Probably the only thing we have in common is that we own shares in Sages's CLE, now selling at $0.001.

I think there are many posters here who look very challenged. Why their inability to avoid personalising and insulting anybody who posts here with views that doubt EUR's success.

I see no chance that Tanbreez will go from laboratory size to a scaled testing and to a pilot plant. If I am right, how would EUR get its money back?

Sage has reduced EUR's cash and cash equivalents at end of the last quarter to $9,571 from $13,145. Buying Tanbreez's unlisted shares was no trivial matter for EUR financially.

As I said, what we have in common are shares in Sage's hopeless CLE.